These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32616158)

  • 1. Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults.
    Zhou Z; Ofori-Asenso R; Curtis AJ; Breslin M; Wolfe R; McNeil JJ; Murray AM; Ernst ME; Reid CM; Lockery JE; Woods RL; Tonkin AM; Nelson MR
    J Am Coll Cardiol; 2020 Jul; 76(1):17-27. PubMed ID: 32616158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of statins for primary prevention of cardiovascular disease and persistent physical disability in older adults.
    Zhou Z; Curtis AJ; Ernst ME; Ryan J; Zoungas S; Wolfe R; McNeil JJ; Murray AM; Reid CM; Chowdhury EK; Woods RL; Tonkin AM; Nelson MR
    Eur J Clin Pharmacol; 2022 Mar; 78(3):467-476. PubMed ID: 34698889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial).
    Zoungas S; Curtis A; Spark S; Wolfe R; McNeil JJ; Beilin L; Chong TT; Cloud G; Hopper I; Kost A; Nelson M; Nicholls SJ; Reid CM; Ryan J; Tonkin A; Ward SA; Wierzbicki A;
    BMJ Open; 2023 Apr; 13(4):e069915. PubMed ID: 37012015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study.
    McNeil JJ; Woods RL; Nelson MR; Murray AM; Reid CM; Kirpach B; Storey E; Shah RC; Wolfe RS; Tonkin AM; Newman AB; Williamson JD; Lockery JE; Margolis KL; Ernst ME; Abhayaratna WP; Stocks N; Fitzgerald SM; Trevaks RE; Orchard SG; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Grimm RH;
    J Gerontol A Biol Sci Med Sci; 2017 Oct; 72(11):1586-1593. PubMed ID: 28329340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older.
    Orkaby AR; Driver JA; Ho YL; Lu B; Costa L; Honerlaw J; Galloway A; Vassy JL; Forman DE; Gaziano JM; Gagnon DR; Wilson PWF; Cho K; Djousse L
    JAMA; 2020 Jul; 324(1):68-78. PubMed ID: 32633800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Chou R; Cantor A; Dana T; Wagner J; Ahmed AY; Fu R; Ferencik M
    JAMA; 2022 Aug; 328(8):754-771. PubMed ID: 35997724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Chou R; Dana T; Blazina I; Daeges M; Jeanne TL
    JAMA; 2016 Nov; 316(19):2008-2024. PubMed ID: 27838722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial.
    ASPREE Investigator Group
    Contemp Clin Trials; 2013 Nov; 36(2):555-64. PubMed ID: 24113028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Aspirin on Disability-free Survival in the Healthy Elderly.
    McNeil JJ; Woods RL; Nelson MR; Reid CM; Kirpach B; Wolfe R; Storey E; Shah RC; Lockery JE; Tonkin AM; Newman AB; Williamson JD; Margolis KL; Ernst ME; Abhayaratna WP; Stocks N; Fitzgerald SM; Orchard SG; Trevaks RE; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Ryan J; Radziszewska B; Grimm R; Murray AM;
    N Engl J Med; 2018 Oct; 379(16):1499-1508. PubMed ID: 30221596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins for primary prevention in adults aged 75 years and older: A nationwide population-based case-control study.
    Jun JE; Cho IJ; Han K; Jeong IK; Ahn KJ; Chung HY; Hwang YC
    Atherosclerosis; 2019 Apr; 283():28-34. PubMed ID: 30772771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Palmer SC; Navaneethan SD; Craig JC; Perkovic V; Johnson DW; Nigwekar SU; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD005019. PubMed ID: 24470059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale.
    Joseph J; Pajewski NM; Dolor RJ; Sellers MA; Perdue LH; Peeples SR; Henrie AM; Woolard N; Jones WS; Benziger CP; Orkaby AR; Mixon AS; VanWormer JJ; Shapiro MD; Kistler CE; Polonsky TS; Chatterjee R; Chamberlain AM; Forman DE; Knowlton KU; Gill TM; Newby LK; Hammill BG; Cicek MS; Williams NA; Decker JE; Ou J; Rubinstein J; Choudhary G; Gazmuri RJ; Schmader KE; Roumie CL; Vaughan CP; Effron MB; Cooper-DeHoff RM; Supiano MA; Shah RC; Whittle JC; Hernandez AF; Ambrosius WT; Williamson JD; Alexander KP;
    J Am Geriatr Soc; 2023 Jun; 71(6):1701-1713. PubMed ID: 37082807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
    McNeil JJ; Wolfe R; Woods RL; Tonkin AM; Donnan GA; Nelson MR; Reid CM; Lockery JE; Kirpach B; Storey E; Shah RC; Williamson JD; Margolis KL; Ernst ME; Abhayaratna WP; Stocks N; Fitzgerald SM; Orchard SG; Trevaks RE; Beilin LJ; Johnston CI; Ryan J; Radziszewska B; Jelinek M; Malik M; Eaton CB; Brauer D; Cloud G; Wood EM; Mahady SE; Satterfield S; Grimm R; Murray AM;
    N Engl J Med; 2018 Oct; 379(16):1509-1518. PubMed ID: 30221597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies.
    Awad K; Mohammed M; Zaki MM; Abushouk AI; Lip GYH; Blaha MJ; Lavie CJ; Toth PP; Jukema JW; Sattar N; Banach M;
    BMC Med; 2021 Jun; 19(1):139. PubMed ID: 34154589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits and Risks Associated With Statin Therapy for Primary Prevention in Old and Very Old Adults : Real-World Evidence From a Target Trial Emulation Study.
    Xu W; Lee AL; Lam CLK; Danaei G; Wan EYF
    Ann Intern Med; 2024 Jun; 177(6):701-710. PubMed ID: 38801776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-Related Trajectories of Cardiovascular Risk and Use of Aspirin and Statin Among U.S. Adults Aged 50 or Older, 2011-2018.
    Rhee TG; Kumar M; Ross JS; Coll PP
    J Am Geriatr Soc; 2021 May; 69(5):1272-1282. PubMed ID: 33598936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia.
    Westin GG; Armstrong EJ; Bang H; Yeo KK; Anderson D; Dawson DL; Pevec WC; Amsterdam EA; Laird JR
    J Am Coll Cardiol; 2014 Feb; 63(7):682-690. PubMed ID: 24315911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins for the primary prevention of cardiovascular disease.
    Taylor F; Ward K; Moore TH; Burke M; Davey Smith G; Casas JP; Ebrahim S
    Cochrane Database Syst Rev; 2011 Jan; (1):CD004816. PubMed ID: 21249663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.